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DYRK kinases are involved in alternative pre-mRNA spli-
cing as well as in neuropathological states such as Alzhei-
mer’s disease and Down syndrome. In this study, we
present the design, synthesis, and biological evaluation of
indirubins as DYRK inhibitors with enhanced selectivity.
Modifications of the bis-indole included polar or acidic
functionalities at positions 5′ and 6′ and a bromine or a
trifluoromethyl group at position 7, affording analogues
that possess high activity and pronounced specificity.
Compound 6i carrying a 5′- carboxylate moiety demon-
strated the best inhibitory profile. A novel inverse binding
mode, which forms the basis for the improved selectivity,
was suggested by molecular modeling and confirmed by
determining the crystal structure of DYRK2 in complex
with 6i. Structure–activity relationships were further
established, including a thermodynamic analysis of binding
site water molecules, offering a structural explanation for
the selective DYRK inhibition [1].
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